Researchers at the University of Toronto have developed a new microfluidic platform called ReSCUE that allows for precise control and manipulation of tumor shapes. This platform offers insights into how tumor shape can predict cancer cell behavior and opens new pathways for personalized cancer care. The ability to recover and release tumoroids from this platform enables downstream analysis and characterization, while also allowing for the growth of cancer organoids in various shapes. Understanding the relationship between tumor shape and cell behavior can help predict tumor aggressiveness and guide treatment strategies. The researchers are continuing to develop the platform to improve drug testing accuracy and better understand cancer cell biology.
Source link
New microfluidic device shows tumor shape predicts cancer aggressiveness
